Emerson Helps Life Sciences Companies Reduce Time to Market with Faster Quality Reviews

Syncade Quality Review Manager for life sciences

Quality Review Manager helps life sciences companies identify and resolve process exceptions early to reduce batch release time and guarantee quality. High resolution image


Enhancements to the Syncade manufacturing execution system streamline the review-by-exception process, turning weeks into days for quality reviews

AUSTIN, TEXAS (May 21, 2018) – Emerson has released Quality Review Manager, a software application designed to reduce the time it takes to release therapies to patients by decreasing the time and effort required for product quality reviews. Delivered as part of the Syncade manufacturing execution system (MES), this new tool helps life sciences companies more easily adopt review-by-exception operating approaches, allowing quality and manufacturing personnel to safely release batches faster, reducing inventory and time to market.

Quality Review Manager significantly reduces the length of reviews by simplifying the process of accurately documenting all actions taken when responding to exceptions. Today most review teams must wait until after an entire batch is complete before reviewing process exceptions. With Quality Review Manager, the quality department can review process exceptions as they occur and while the batch is still in process, providing a more accurate and timely response. Exception reviews can be completed within hours of the exception occurring rather than weeks after the batch has been completed, eliminating potential delays in releasing product to patients.

Providing a single environment for reviewing exceptions, Quality Review Manager speeds up the process of managing exception documentation by autogenerating data that provides context for each exception. Exception dashboards help prioritise reviews while focusing on the most critical exceptions affecting the process. After all exceptions are closed, Quality Review Manager supports an automated release methodology by immediately releasing finished batches once all exceptions are resolved, thereby reducing the lag between production, product release and patient delivery.

The web-enabled tool, accessible through traditional workstations and modern mobile devices (e.g., tablet or smart phone), facilitates collaboration among stakeholders and quality personnel by making documentation and other relevant information available anywhere.

“Quality is paramount in the life sciences industry, so exception reviews must be supported by fully connected systems that deliver data integrity,” said John Nita, vice president of sales and product management for Emerson’s life sciences business. “Quality Review Manager provides a single source of the truth, helping to streamline exception reporting and resolution, ultimately improving operating performance and helping medicines reach patients faster.”

Visit www.Emerson.com/Syncade for more information. 

Media:
• Contacts: Emerson Global Media Contacts

Additional resources:
• Join the Emerson Exchange 365 Community
• Connect with Emerson via X Facebook LinkedIn YouTube

About Emerson 
Emerson (NYSE: EMR) is a global technology and software company providing innovative solutions for the world’s essential industries. Through its leading automation portfolio, including its majority stake in AspenTech, Emerson helps hybrid, process and discrete manufacturers optimize operations, protect personnel, reduce emissions and achieve their sustainability goals. For more information, visit Emerson.com.

Please enable JavaScript to use this website.